Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: A multicentric prospective study

Seizure - Tập 22 - Trang 77-79 - 2013
J. Miró1,2, M. Toledo3, E. Santamarina3, A.C. Ricciardi4, V. Villanueva5, A. Pato6, J. Ruiz7, R. Juvany8, M. Falip1,2
1Epilepsy Unit, Hospital de Bellvitge, Hospitalet de Llobregat, 08907 Barcelona, Spain
2Cognition and Brain Plasticity Group, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Spain
3Epilepsy Unit, Hospital Universitari de la Vall d’Hebron, Barcelona, Spain
4Hospital General de Granollers, Granollers, Spain
5Epilepsy Unit, Hospital la Fe, Valencia, Spain
6Epilepsy Unit, Hospital de Povisa, Vigo, Spain
7Epilepsy Unit, Hospital Virgen de las Nieves, Granada, Spain
8Pharmacy Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain

Tài liệu tham khảo

Chen, 2006, Status epilepticus: pathophysiology and management in adults, Lancet Neurology, 5, 246, 10.1016/S1474-4422(06)70374-X Meierkord, 2010, EFNS guideline on the management of status epilepticus, European Journal of Neurology, 17, 348, 10.1111/j.1468-1331.2009.02917.x Lowenstein, 2006, The management of refractory status epilepticus: an update, Epilepsia, 47, 35, 10.1111/j.1528-1167.2006.00658.x Treiman, 1998, A comparison of four treatments for generalized convulsive status epilepticus, Veterans Affairs Status Epilepticus Cooperative Study Group, The New England Journal of Medicine, 339, 792, 10.1056/NEJM199809173391202 Shorvon, 2011, The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol, Brain, 134, 2082, 10.1093/brain/awr215 Gilad, 2008, Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin i.v., Acta Neurologica Scandinavia, 118, 296, 10.1111/j.1600-0404.2008.01097.x Novy, 2010, Refractory status epilepticus: a prospective observational study, Epilepsia, 51, 251, 10.1111/j.1528-1167.2009.02323.x Aiguabella, 2011, Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study, Seizure, 20, 60, 10.1016/j.seizure.2010.10.009 Misra, 2012, Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study, Journal of Neurology, 259, 645, 10.1007/s00415-011-6227-2 Alvarez, 2011, Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam, Epilepsia, 52, 1292, 10.1111/j.1528-1167.2011.03056.x Kellinghaus, 2011, Intravenous lacosamide for treatment of status epilepticus, Acta Neurologica Scandinavia, 123, 127, 10.1111/j.1600-0404.2010.01423.x Albers, 2011, Intravenous lacosamide – an effective add-on treatment of refractory status epilepticus, Seizure, 20, 428, 10.1016/j.seizure.2011.01.017 Höfler, 2011, Intravenous lacosamide in status epilepticus and seizure clusters, Epilepsia, 52, e148, 10.1111/j.1528-1167.2011.03204.x Mantsakanyan, 2012, Intravenous lacosamide in refractory nonconvulsive status epilepticus, Seizure, 21, 198, 10.1016/j.seizure.2011.12.008 Wasterlain, 2011, The acute and chronic effects of the novel anticonvulsivant lacosamide in an experimental model of status epilepticus, Epilepsy Research, 94, 10, 10.1016/j.eplepsyres.2010.12.014